Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Jennifer J. Furin, M.D., Ph.D.

Title
Institution
Department
Address
Phone

Mentoring
Evaluating an intervention program addressing the health priorities of women and children in the Carabayllo community of Lima, Peru
International, 10/01/05 - 03/31/06
Scaling-up antiretrovirals in rural Lesotho: Lessons from the field
International, 06/23/06 - 08/18/06
Clinical Elective at McCord Hospital (Durban, South Africa) - spring 2008
International, 03/31/08 - 04/27/08
Chest radiograph findings and tuberculosis diagnosis in HIV infected patients in rural Lesotho
International, 06/16/07 - 08/10/07

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Akkerman OW, Duarte R, Tiberi S, Schaaf HS, Lange C, Alffenaar JWC, Denholm J, Carvalho ACC, Bolhuis MS, Borisov S, Bruchfeld J, Cabibbe AM, Caminero JA, Carvalho I, Chakaya J, Centis R, Dalcomo MP, D Ambrosio L, Dedicoat M, Dheda K, Dooley KE, Furin J, García-García JM, van Hest NAH, de Jong BC, Kurhasani X, Märtson AG, Mpagama S, Torrico MM, Nunes E, Ong CWM, Palmero DJ, Ruslami R, Saktiawati AMI, Semuto C, Silva DR, Singla R, Solovic I, Srivastava S, de Steenwinkel JEM, Story A, Sturkenboom MGG, Tadolini M, Udwadia ZF, Verhage AR, Zellweger JP, Migliori GB. Clinical standards for drug-susceptible pulmonary TB. Int J Tuberc Lung Dis. 2022 07 01; 26(7):592-604. PMID: 35768923; PMCID: PMC9272737.
    Citations:    Fields:    Translation:Humans
  2. Memani B, Beko B, Dumile N, Mohr-Holland E, Daniels J, Sibanda B, Damse Z, Scott V, von der Heyden E, Pfaff C, Reuter A, Furin J. Causes of loss to follow-up from drug-resistant TB treatment in Khayelitsha, South Africa. Public Health Action. 2022 Jun 21; 12(2):55-57. PMID: 35734003; PMCID: PMC9176197.
    Citations:    
  3. Furin J, Isaakidis P. Being heard on all-oral therapy for resistant tuberculosis. Lancet Infect Dis. 2022 07; 22(7):923-924. PMID: 35512717.
    Citations:    Fields:    Translation:HumansCells
  4. Reuter A, Furin J. Helping hospitals heal people with HIV and tuberculosis. Lancet HIV. 2022 04; 9(4):e224-e225. PMID: 35338836.
    Citations:    Fields:    Translation:Humans
  5. Apolisi I, Mema N, Tyeku N, Beko B, Memani B, Daniels J, Cengani L, Fatshe S, Gumede N, Makhalima M, Mathee S, Matthews G, Ngambu N, Ryan A, Scott V, Giddy J, Furin J, Reuter A. Supporting families with tuberculosis during COVID-19 in Khayelithsa, South Africa. Lancet Respir Med. 2022 06; 10(6):542-543. PMID: 35338838; PMCID: PMC8942477.
    Citations:    Fields:    Translation:HumansCells
  6. Cox H, Goig GA, Salaam-Dreyer Z, Dippenaar A, Reuter A, Mohr-Holland E, Daniels J, Cudahy PGT, Nicol MP, Borrell S, Reinhard M, Doetsch A, Beisel C, Gagneux S, Warren RM, Furin J. Whole-Genome Sequencing Has the Potential To Improve Treatment for Rifampicin-Resistant Tuberculosis in High-Burden Settings: a Retrospective Cohort Study. J Clin Microbiol. 2022 03 16; 60(3):e0236221. PMID: 35170980; PMCID: PMC8925891.
    Citations: 1     Fields:    Translation:HumansCells
  7. Mohr-Holland E, Daniels J, Reuter A, Rodriguez CA, Mitnick C, Kock Y, Cox V, Furin J, Cox H. Early mortality during rifampicin-resistant TB treatment. Int J Tuberc Lung Dis. 2022 Feb 01; 26(2):150-157. PMID: 35086627; PMCID: PMC8802559.
    Citations:    Fields:    Translation:HumansCells
  8. Reuter A, Beko B, Memani B, Furin J, Daniels J, Rodriguez E, Reuter H, Weich L, Isaakidis P, von der Heyden E, Kock Y, Mohr-Holland E. Implementing a Substance-Use Screening and Intervention Program for People Living with Rifampicin-Resistant Tuberculosis: Pragmatic Experience from Khayelitsha, South Africa. Trop Med Infect Dis. 2022 Jan 31; 7(2). PMID: 35202216; PMCID: PMC8879094.
    Citations: 1     
  9. Moscibrodzki P, Enane LA, Hoddinott G, Brooks MB, Byron V, Furin J, Seddon JA, Meyersohn L, Chiang SS. The Impact of Tuberculosis on the Well-Being of Adolescents and Young Adults. Pathogens. 2021 Dec 08; 10(12). PMID: 34959546; PMCID: PMC8706072.
    Citations: 3     
  10. Furin J. The potential perils of a drug protection framework in tuberculosis. Lancet Infect Dis. 2022 04; 22(4):432-433. PMID: 34780707.
    Citations:    Fields:    Translation:HumansCells
  11. Hiremath A, Bera K, Yuan L, Vaidya P, Alilou M, Furin J, Armitage K, Gilkeson R, Ji M, Fu P, Gupta A, Lu C, Madabhushi A. Integrated Clinical and CT Based Artificial Intelligence Nomogram for Predicting Severity and Need for Ventilator Support in COVID-19 Patients: A Multi-Site Study. IEEE J Biomed Health Inform. 2021 11; 25(11):4110-4118. PMID: 34388099; PMCID: PMC8709885.
    Citations:    Fields:    Translation:HumansCells
  12. Tack I, Dumicho A, Ohler L, Shigayeva A, Bulti AB, White K, Mbatha M, Furin J, Isaakidis P. Safety and Effectiveness of an All-Oral, Bedaquiline-Based, Shorter Treatment Regimen for Rifampicin-Resistant Tuberculosis in High Human Immunodeficiency Virus (HIV) Burden Rural South Africa: A Retrospective Cohort Analysis. Clin Infect Dis. 2021 11 02; 73(9):e3563-e3571. PMID: 33372989.
    Citations: 5     Fields:    Translation:HumansCells
  13. Cox H, Salaam-Dreyer Z, Goig GA, Nicol MP, Menardo F, Dippenaar A, Mohr-Holland E, Daniels J, Cudahy PGT, Borrell S, Reinhard M, Doetsch A, Beisel C, Reuter A, Furin J, Gagneux S, Warren RM. Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology study. Lancet Microbe. 2021 11; 2(11):e584-e593. PMID: 34766068; PMCID: PMC8563432.
    Citations: 4     Translation:HumansCells
  14. Udwadia ZF, Furin J. India should speed up access to bedaquiline-based all-oral regimens, not procrastinate further. Lung India. 2021 Nov-Dec; 38(6):590-591. PMID: 34747748.
    Citations:    
  15. Loveday M, Hlangu S, Larkan LM, Cox H, Daniels J, Mohr-Holland E, Furin J. "This is not my body": Therapeutic experiences and post-treatment health of people with rifampicin-resistant tuberculosis. PLoS One. 2021; 16(10):e0251482. PMID: 34662887.
    Citations:    Fields:    Translation:Humans
  16. Horter S, Daftary A, Keam T, Bernays S, Bhanushali K, Chavan D, Denholm J, Furin J, Jaramillo E, Khan A, Lin YD, Lobo R, Loveday M, Majumdar SS, Mistry N, Patel H, Rane S, Swaminathan A, Triasih R, Venkatesan N, Viney K, du Cros P. Person-centred care in TB. Int J Tuberc Lung Dis. 2021 10 01; 25(10):784-787. PMID: 34615573.
    Citations: 2     Fields:    Translation:Humans
  17. Migliori GB, Marx FM, Ambrosino N, Zampogna E, Schaaf HS, van der Zalm MM, Allwood B, Byrne AL, Mortimer K, Wallis RS, Fox GJ, Leung CC, Chakaya JM, Seaworth B, Rachow A, Marais BJ, Furin J, Akkerman OW, Al Yaquobi F, Amaral AFS, Borisov S, Caminero JA, Carvalho ACC, Chesov D, Codecasa LR, Teixeira RC, Dalcolmo MP, Datta S, Dinh-Xuan AT, Duarte R, Evans CA, García-García JM, Günther G, Hoddinott G, Huddart S, Ivanova O, Laniado-Laborín R, Manga S, Manika K, Mariandyshev A, Mello FCQ, Mpagama SG, Muñoz-Torrico M, Nahid P, Ong CWM, Palmero DJ, Piubello A, Pontali E, Silva DR, Singla R, Spanevello A, Tiberi S, Udwadia ZF, Vitacca M, Centis R, D Ambrosio L, Sotgiu G, Lange C, Visca D. Clinical standards for the assessment, management and rehabilitation of post-TB lung disease. Int J Tuberc Lung Dis. 2021 10 01; 25(10):797-813. PMID: 34615577; PMCID: PMC8504493.
    Citations: 13     Fields:    Translation:Humans
  18. Zimmer AJ, Klinton JS, Oga-Omenka C, Heitkamp P, Nawina Nyirenda C, Furin J, Pai M. Tuberculosis in times of COVID-19. J Epidemiol Community Health. 2022 03; 76(3):310-316. PMID: 34535539; PMCID: PMC8453591.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  19. Mitnick CD, Furin JJ, Hewison C. The Reductionist Conundrum of an "Updated" Definition of Extensively Drug-Resistant Tuberculosis. Am J Respir Crit Care Med. 2021 09 15; 204(6):629-631. PMID: 34375572; PMCID: PMC8521709.
    Citations:    Fields:    Translation:Humans
  20. Cox H, Furin J. The incalculable costs of tuberculosis. Lancet Glob Health. 2021 10; 9(10):e1337-e1338. PMID: 34487684.
    Citations:    Fields:    Translation:Humans
  21. Chesov D, Makhanda G, Furin J. Tackling the many layers of stigma is essential for the "End TB Strategy". Int J Tuberc Lung Dis. 2021 09 01; 25(9):683-684. PMID: 34802485.
    Citations:    Fields:    Translation:Humans
  22. Mohr-Holland E, Hacking D, Daniels J, Scott V, Mudaly V, Furin J, Pfaff C, Reuter A. Diagnosis patterns for rifampicin-resistant TB after onset of COVID-19. Int J Tuberc Lung Dis. 2021 09 01; 25(9):772-775. PMID: 34802503.
    Citations:    Fields:    Translation:HumansCells
  23. Douglas-Jones B, Mohr-Holland E, Mema N, Mathee S, Mathews G, Hurribance S, Scott V, Reuter A, Furin J, Pfaff C. A home-based care programme for rifampicin-resistant TB. Int J Tuberc Lung Dis. 2021 07 01; 25(7):587-589. PMID: 34183106.
    Citations:    Fields:    Translation:HumansCells
  24. Reuter A, Furin J. Treating Drug-resistant Tuberculosis Infection: No More Excuses. Clin Infect Dis. 2021 05 18; 72(10):1716-1718. PMID: 32266941.
    Citations:    Fields:    Translation:Humans
  25. Zokufa N, Lebelo K, Hacking D, Tabo L, Runeyi P, Malabi N, Sibanda SB, Cassidy T, Makanda G, Norman B, Khuzani S, Furin J, Jonker C, Nkasana B, Scott V, Pfaff C. Community-based TB testing as an essential part of TB recovery plans in the COVID-19 era. Int J Tuberc Lung Dis. 2021 May 01; 25(5):406-408. PMID: 33977911.
    Citations: 2     Fields:    Translation:HumansCells
  26. Mohr-Holland E, Daniels J, Douglas-Jones B, Mema N, Scott V, Trivino-Duran L, Pfaff C, Furin J, Isaakidis P. A positive COVID-19 test is associated with high mortality in RR-TB-HIV patients. Int J Tuberc Lung Dis. 2021 May 01; 25(5):409-412. PMID: 33977912.
    Citations: 2     Fields:    Translation:HumansCells
  27. Acquah R, Mohr-Holland E, Daniels J, Furin J, Loveday M, Mudaly V, Reuter A. Outcomes of Children Born to Pregnant Women With Drug-resistant Tuberculosis Treated With Novel Drugs in Khayelitsha, South Africa: A Report of Five Patients. Pediatr Infect Dis J. 2021 05 01; 40(5):e191-e192. PMID: 33847295.
    Citations: 1     Fields:    Translation:Humans
  28. Furin J. Iqbal Haroon Master, 1962-2021. Int J Tuberc Lung Dis. 2021 04 01; 25(4):332. PMID: 33762082.
    Citations:    Fields:    
  29. Cox V, Guglielmetti L, Hewison C, Reuter A, Furin J. Reply to: "Human rights: finding the right balance for rifampicin-resistant TB treatment". Int J Tuberc Lung Dis. 2021 04 01; 25(4):328-329. PMID: 33762080.
    Citations:    Fields:    Translation:Humans
  30. Kirtane AR, Verma M, Karandikar P, Furin J, Langer R, Traverso G. Nanotechnology approaches for global infectious diseases. Nat Nanotechnol. 2021 04; 16(4):369-384. PMID: 33753915.
    Citations: 31     Fields:    Translation:Humans
  31. Mohr-Holland E, Douglas-Jones B, Apolisi I, Ngambu N, Mathee S, Cariem R, Mudaly V, Pfaff C, Isaakidis P, Furin J, Reuter A. Tuberculosis preventive therapy for children and adolescents: an emergency response to the COVID-19 pandemic. Lancet Child Adolesc Health. 2021 03; 5(3):159-161. PMID: 33609490.
    Citations: 4     Fields:    Translation:Humans
  32. Loveday M, Hlangu S, Furin J. "Take the treatment and be brave": Care experiences of pregnant women with rifampicin-resistant tuberculosis. PLoS One. 2020; 15(12):e0242604. PMID: 33347448; PMCID: PMC7751874.
    Citations: 1     Fields:    Translation:HumansCells
  33. Das M, Mamnoon F, Mansoor H, Meneguim AC, Singh P, Shah I, Ravi S, Kalon S, Hossain FN, Ferlazzo G, Isaakidis P, Furin J, Acharya S, Thakur HP. New TB drugs for the treatment of children and adolescents with rifampicin-resistant TB in Mumbai, India. Int J Tuberc Lung Dis. 2020 12 01; 24(12):1265-1271. PMID: 33317670.
    Citations: 4     Fields:    Translation:Humans
  34. Daftary A, Furin J, Zelnick JR, Venkatesan N, Steingart K, Smelyanskaya M, Seepamore B, Schoeman I, Reid M, Padayatchi N, O Donnell MR, Mistry N, McKenna L, Mahbub T, Macdonald H, Loveday M, Law S, LaCourse SM, Jaramillo E, Janssen R, Hirsch-Moverman Y, Friedland G, Creswell J, Chorna Y, Chikovore J, Brigden G, Boffa J, Boehme C, Atre S, Amico KR, Acquah R, Engel N. TB and women: a call to action. Int J Tuberc Lung Dis. 2020 12 01; 24(12):1312-1315. PMID: 33317679.
    Citations:    Fields:    Translation:Humans
  35. Nash M, Perrin C, Seddon JA, Furin J, Hauser J, Marais B, Kitai I, Starke J, McKenna L. Access to paediatric formulations for the treatment of childhood tuberculosis. Lancet Child Adolesc Health. 2020 12; 4(12):855-857. PMID: 33217352.
    Citations:    Fields:    Translation:Humans
  36. Loveday M, Cox H, Evans D, Furin J, Ndjeka N, Osman M, Naidoo For The National Tb Think Tank 'Optimising Tb Treatment Outcomes' Task Team K. Opportunities from a new disease for an old threat: Extending COVID-19 efforts to address tuberculosis in South Africa. S Afr Med J. 2020 11 05; 110(12):1160-1167. PMID: 33403958.
    Citations: 12     Fields:    Translation:HumansCellsPHPublic Health
  37. Cox V, McKenna L, Acquah R, Reuter A, Wasserman S, Vambe D, Ustero P, Udwadia Z, Triviño-Duran L, Tommasi M, Skrahina A, Seddon JA, Rodolfo R, Rich M, Padanilam X, Oyewusi L, Ohler L, Lungu P, Loveday M, Khan U, Khan P, Hughes J, Hewison C, Guglielmetti L, Furin J. Clinical perspectives on treatment of rifampicin-resistant/multidrug-resistant TB. Int J Tuberc Lung Dis. 2020 11 01; 24(11):1134-1144. PMID: 33172520.
    Citations: 3     Fields:    Translation:Humans
  38. Vambe D, Kay AW, Furin J, Howard AA, Dlamini T, Dlamini N, Shabangu A, Hassen F, Masuku S, Maha O, Wawa C, Mafukidze A, Altaye K, Sikhondze W, Gwitima T, Keus K, Simelane T, Kerschberger B. Bedaquiline and delamanid result in low rates of unfavourable outcomes among TB patients in Eswatini. Int J Tuberc Lung Dis. 2020 10 01; 24(10):1095-1102. PMID: 33126945.
    Citations: 2     Fields:    Translation:Humans
  39. Furin J, Akkerman OW. Hope rises out of despair: bedaquiline and linezolid for the treatment of drug-resistant TB. Int J Tuberc Lung Dis. 2020 10 01; 24(10):987-988. PMID: 33126928.
    Citations: 1     Fields:    Translation:Humans
  40. Dousa KM, Kurz SG, Bark CM, Bonomo RA, Furin JJ. Drug-Resistant Tuberculosis: A Glance at Progress and Global Challenges. Infect Dis Clin North Am. 2020 12; 34(4):863-886. PMID: 33011048.
    Citations: 3     Fields:    Translation:HumansCells
  41. Loveday M, Hlangu S, Furin J. Breastfeeding in women living with tuberculosis. Int J Tuberc Lung Dis. 2020 09 01; 24(9):880-891. PMID: 33156754.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  42. Keene C, Mohr-Holland E, Cassidy T, Scott V, Nelson A, Furin J, Triviño-Duran L. How COVID-19 could benefit tuberculosis and HIV services in South Africa. Lancet Respir Med. 2020 09; 8(9):844-846. PMID: 32758439.
    Citations: 17     Fields:    Translation:HumansCellsPHPublic Health
  43. Mohr-Holland E, Reuter A, Hughes J, Daniels J, Beko B, Makhanda G, De Avezedo V, Kock Y, Cox H, Furin J, Trivino Duran L, Isaakidis P, Ferlazzo G. Correspondence regarding "Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa". Eur Respir J. 2020 07; 56(1). PMID: 32703820.
    Citations: 1     Fields:    Translation:Humans
  44. Reuter A, Furin J. The problem with vitamin D supplementation for tuberculosis. Lancet HIV. 2020 07; 7(7):e450-e451. PMID: 32621871.
    Citations:    Fields:    Translation:Humans
  45. Wasserman S, Furin J. Clarity with INHindsight: High-Dose Isoniazid for Drug-Resistant Tuberculosis with inhA Mutations. Am J Respir Crit Care Med. 2020 06 01; 201(11):1331-1333. PMID: 32078783; PMCID: PMC7258653.
    Citations:    Fields:    Translation:Humans
  46. Furin J. Can Green Light Committees help "end TB"? Int J Tuberc Lung Dis. 2020 05 01; 24(5):540. PMID: 32398209.
    Citations:    Fields:    Translation:Humans
  47. Dousa KM, Malavade SS, Furin J, Gripshover B, Hatszegi M, Hojat L, Saade E, Salata RA. SARS-CoV-2 infection in a patient on chronic hydroxychloroquine therapy: Implications for prophylaxis. IDCases. 2020; 20:e00778. PMID: 32341910.
    Citations: 6     
  48. Reuter A, Seddon JA, Marais BJ, Furin J. Preventing tuberculosis in children: A global health emergency. Paediatr Respir Rev. 2020 Nov; 36:44-51. PMID: 32253128.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  49. Mohr-Holland E, Reuter A, Furin J, Garcia-Prats A, De Azevedo V, Mudaly V, Kock Y, Trivino-Duran L, Isaakidis P, Hughes J. Injectable-free regimens containing bedaquiline, delamanid, or both for adolescents with rifampicin-resistant tuberculosis in Khayelitsha, South Africa. EClinicalMedicine. 2020 Mar; 20:100290. PMID: 32154506; PMCID: PMC7057194.
    Citations: 3     
  50. Furin J, Loveday M, Hlangu S, Dickson-Hall L, le Roux S, Nicol M, Cox H. "A very humiliating illness": a qualitative study of patient-centered Care for Rifampicin-Resistant Tuberculosis in South Africa. BMC Public Health. 2020 Jan 17; 20(1):76. PMID: 31952494; PMCID: PMC6969445.
    Citations: 13     Fields:    Translation:Humans
  51. Mohr-Holland E, Apolisi I, Reuter A, de Azevedo V, Hill J, Matthee S, Seddon JA, Isaakidis P, Furin J, Trivino-Duran L. Barriers and solutions to finding rifampicin-resistant tuberculosis cases in older children and adolescents. Public Health Action. 2019 Dec 21; 9(4):174-176. PMID: 32042611.
    Citations:    
  52. McKenna L, Furin J. Are pretomanid-containing regimens for tuberculosis a victory or a victory narrative? Lancet Respir Med. 2019 12; 7(12):999-1000. PMID: 31732486.
    Citations: 1     Fields:    Translation:Humans
  53. Reuter A, Hughes J, Furin J. Challenges and controversies in childhood tuberculosis. Lancet. 2019 Sep 14; 394(10202):967-978. PMID: 31526740.
    Citations: 11     Fields:    Translation:HumansPHPublic Health
  54. Buziashvili M, Mirtskhulava V, Kipiani M, Blumberg HM, Baliashvili D, Magee MJ, Furin JJ, Tukvadze N, Kempker RR. Rates and risk factors for nephrotoxicity and ototoxicity among tuberculosis patients in Tbilisi, Georgia. Int J Tuberc Lung Dis. 2019 09 01; 23(9):1005-1011. PMID: 31615608; PMCID: PMC6989218.
    Citations: 3     Fields:    Translation:Humans
  55. Dheda K, Gumbo T, Maartens G, Dooley KE, Murray M, Furin J, Nardell EA, Warren RM. The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis. Lancet Respir Med. 2019 09; 7(9):820-826. PMID: 31486393.
    Citations: 32     Fields:    Translation:Humans
  56. Furin J, Frick M, McKenna L. A human rights-based approach to tuberculosis diagnosis. Int J Tuberc Lung Dis. 2019 08 01; 23(8):959. PMID: 31533888.
    Citations:    Fields:    Translation:Humans
  57. Udwadia Z, Furin J. Quality of drug-resistant tuberculosis care: Gaps and solutions. J Clin Tuberc Other Mycobact Dis. 2019 Aug; 16:100101. PMID: 31720427; PMCID: PMC6830144.
    Citations: 4     
  58. Furin J, Sotgiu G. Protecting those who serve: are we doing enough to prevent tuberculosis in healthcare workers? Eur Respir J. 2019 Apr; 53(4). PMID: 31000668.
    Citations:    Fields:    Translation:Humans
  59. Loveday M, Reuter A, Furin J, Seddon JA, Cox H. The STREAM trial: missed opportunities and lessons for future clinical trials. Lancet Infect Dis. 2019 04; 19(4):351-353. PMID: 30910428.
    Citations: 1     Fields:    Translation:Humans
  60. Reid MJA, Arinaminpathy N, Bloom A, Bloom BR, Boehme C, Chaisson R, Chin DP, Churchyard G, Cox H, Ditiu L, Dybul M, Farrar J, Fauci AS, Fekadu E, Fujiwara PI, Hallett TB, Hanson CL, Harrington M, Herbert N, Hopewell PC, Ikeda C, Jamison DT, Khan AJ, Koek I, Krishnan N, Motsoaledi A, Pai M, Raviglione MC, Sharman A, Small PM, Swaminathan S, Temesgen Z, Vassall A, Venkatesan N, van Weezenbeek K, Yamey G, Agins BD, Alexandru S, Andrews JR, Beyeler N, Bivol S, Brigden G, Cattamanchi A, Cazabon D, Crudu V, Daftary A, Dewan P, Doepel LK, Eisinger RW, Fan V, Fewer S, Furin J, Goldhaber-Fiebert JD, Gomez GB, Graham SM, Gupta D, Kamene M, Khaparde S, Mailu EW, Masini EO, McHugh L, Mitchell E, Moon S, Osberg M, Pande T, Prince L, Rade K, Rao R, Remme M, Seddon JA, Selwyn C, Shete P, Sachdeva KS, Stallworthy G, Vesga JF, Vilc V, Goosby EP. Building a tuberculosis-free world: The Lancet Commission on tuberculosis. Lancet. 2019 Mar 30; 393(10178):1331-1384. PMID: 30904263.
    Citations: 104     Fields:    Translation:HumansCellsPHPublic Health
  61. Furin J, Cox H, Pai M. Tuberculosis. Lancet. 2019 Apr 20; 393(10181):1642-1656. PMID: 30904262.
    Citations: 152     Fields:    Translation:Humans
  62. Verma M, Vishwanath K, Eweje F, Roxhed N, Grant T, Castaneda M, Steiger C, Mazdiyasni H, Bensel T, Minahan D, Soares V, Salama JAF, Lopes A, Hess K, Cleveland C, Fulop DJ, Hayward A, Collins J, Tamang SM, Hua T, Ikeanyi C, Zeidman G, Mule E, Boominathan S, Popova E, Miller JB, Bellinger AM, Collins D, Leibowitz D, Batra S, Ahuja S, Bajiya M, Batra S, Sarin R, Agarwal U, Khaparde SD, Gupta NK, Gupta D, Bhatnagar AK, Chopra KK, Sharma N, Khanna A, Chowdhury J, Stoner R, Slocum AH, Cima MJ, Furin J, Langer R, Traverso G. A gastric resident drug delivery system for prolonged gram-level dosing of tuberculosis treatment. Sci Transl Med. 2019 03 13; 11(483). PMID: 30867322.
    Citations: 7     Fields:    Translation:HumansAnimalsCells
  63. Osman M, Harausz EP, Garcia-Prats AJ, Schaaf HS, Moore BK, Hicks RM, Achar J, Amanullah F, Barry P, Becerra M, Chiotan DI, Drobac PC, Flood J, Furin J, Gegia M, Isaakidis P, Mariandyshev A, Ozere I, Shah NS, Skrahina A, Yablokova E, Seddon JA, Hesseling AC. Treatment Outcomes in Global Systematic Review and Patient Meta-Analysis of Children with Extensively Drug-Resistant Tuberculosis. Emerg Infect Dis. 2019 03; 25(3):441-450. PMID: 30789141.
    Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
  64. Loveday M, Hlangu S, Furin J. Healthcare Provider Discrimination toward Pregnant Women with Rifampin-Resistant Tuberculosis. Emerg Infect Dis. 2019 03; 25(3):609-610. PMID: 30789334; PMCID: PMC6390748.
    Citations: 4     Fields:    Translation:Humans
  65. Acquah R, Furin J. Universal regimens or universal access to drug susceptibility testing for tuberculosis? Lancet Infect Dis. 2019 03; 19(3):224-225. PMID: 30744961.
    Citations: 2     Fields:    Translation:HumansCells
  66. Verma M, Furin J, Langer R, Traverso G. Making the case: developing innovative adherence solutions for the treatment of tuberculosis. BMJ Glob Health. 2019; 4(1):e001323. PMID: 30815283; PMCID: PMC6361324.
    Citations: 3     Fields:    
  67. Furin J. Advances in the diagnosis, treatment, and prevention of tuberculosis in children. Expert Rev Respir Med. 2019 03; 13(3):301-311. PMID: 30648437.
    Citations: 6     Fields:    Translation:Humans
  68. Fargher J, Reuter A, Furin J. Demanding an end to tuberculosis: treatment of tuberculosis infection among persons living with and without HIV. Curr Opin HIV AIDS. 2019 01; 14(1):21-27. PMID: 30407203.
    Citations:    Fields:    Translation:HumansCells
  69. Lange C, Chesov D, Furin J, Udwadia Z, Dheda K. Revising the definition of extensively drug-resistant tuberculosis. Lancet Respir Med. 2018 12; 6(12):893-895. PMID: 30420247.
    Citations: 1     Fields:    Translation:Humans
  70. Monedero-Recuero I, Hernando-Marrupe L, Sánchez-Montalvá A, Cox V, Tommasi M, Furin J, Chiang CY, Quelapio M, Koura KG, Trébucq A, Padanilam X, Dravniece G, Piubello A. QTc and anti-tuberculosis drugs: a perfect storm or a tempest in a teacup? Review of evidence and a risk assessment. Int J Tuberc Lung Dis. 2018 Oct 26. PMID: 30366516.
    Citations: 8     Fields:    
  71. Cruz AT, Garcia-Prats AJ, Furin J, Seddon JA. Treatment of Multidrug-Resistant Tuberculosis Infection in Children. Pediatr Infect Dis J. 2018 10; 37(10):1061-1064. PMID: 30216296.
    Citations: 2     Fields:    Translation:HumansCells
  72. Reuter A, Furin J. Reducing harm in the treatment of multidrug-resistant tuberculosis. Lancet. 2018 09 08; 392(10150):797-798. PMID: 30215367.
    Citations: 2     Fields:    Translation:HumansCells
  73. Seddon JA, Schaaf HS, Marais BJ, McKenna L, Garcia-Prats AJ, Hesseling AC, Hughes J, Howell P, Detjen A, Amanullah F, Singh U, Master I, Perez-Velez CM, Misra N, Becerra MC, Furin JJ. Time to act on injectable-free regimens for children with multidrug-resistant tuberculosis. Lancet Respir Med. 2018 09; 6(9):662-664. PMID: 30191832.
    Citations: 8     Fields:    Translation:Humans
  74. Koenig SP, Furin J. Providing quality care on the border with Haiti. Lancet. 2018 08 04; 392(10145):382. PMID: 30102166.
    Citations:    Fields:    
  75. Cruz AT, Garcia-Prats AJ, Furin J, Seddon JA. Treatment of Multidrug-resistant Tuberculosis Infection in Children. Pediatr Infect Dis J. 2018 08; 37(8):831-834. PMID: 29742640.
    Citations: 2     Fields:    Translation:HumansCells
  76. Reuter A, Furin J. Bedaquiline use in South Africa reveals a lifesaving policy in action. Lancet Respir Med. 2018 09; 6(9):653-655. PMID: 30001995.
    Citations: 2     Fields:    Translation:Humans
  77. Harausz EP, Garcia-Prats AJ, Law S, Schaaf HS, Kredo T, Seddon JA, Menzies D, Turkova A, Achar J, Amanullah F, Barry P, Becerra M, Chan ED, Chan PC, Ioana Chiotan D, Crossa A, Drobac PC, Fairlie L, Falzon D, Flood J, Gegia M, Hicks RM, Isaakidis P, Kadri SM, Kampmann B, Madhi SA, Marais E, Mariandyshev A, Méndez-Echevarría A, Moore BK, Nargiza P, Ozere I, Padayatchi N, Ur-Rehman S, Rybak N, Santiago-Garcia B, Shah NS, Sharma S, Shim TS, Skrahina A, Soriano-Arandes A, van den Boom M, van der Werf MJ, van der Werf TS, Williams B, Yablokova E, Yim JJ, Furin J, Hesseling AC. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis. PLoS Med. 2018 07; 15(7):e1002591. PMID: 29995958.
    Citations: 36     Fields:    Translation:Humans
  78. Mohr E, Hughes J, Reuter A, Trivino Duran L, Ferlazzo G, Daniels J, De Azevedo V, Kock Y, Steele SJ, Shroufi A, Ade S, Alikhanova N, Benedetti G, Edwards J, Cox H, Furin J, Isaakidis P. Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa. Eur Respir J. 2018 06; 51(6). PMID: 29724920.
    Citations: 7     Fields:    Translation:Humans
  79. Dheda K, Gumbo T, Lange C, Horsburgh CR, Furin J. Pan-tuberculosis regimens: an argument against. Lancet Respir Med. 2018 04; 6(4):240-242. PMID: 29595502.
    Citations: 6     Fields:    Translation:HumansCells
  80. Cox V, Brigden G, Crespo RH, Lessem E, Lynch S, Rich ML, Waning B, Furin J. Global programmatic use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2018 04 01; 22(4):407-412. PMID: 29562988.
    Citations: 13     Fields:    Translation:Humans
  81. Furin J, Tommasi M, Garcia-Prats AJ. Drug-resistant tuberculosis: will grand promises fail children and adolescents? Lancet Child Adolesc Health. 2018 04; 2(4):237-238. PMID: 30169295.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  82. Ferlazzo G, Mohr E, Laxmeshwar C, Hewison C, Hughes J, Jonckheere S, Khachatryan N, De Avezedo V, Egazaryan L, Shroufi A, Kalon S, Cox H, Furin J, Isaakidis P. Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study. Lancet Infect Dis. 2018 05; 18(5):536-544. PMID: 29452942.
    Citations: 28     Fields:    Translation:Humans
  83. Alsultan A, Furin JJ, Du Bois J, van Brakel E, Chheng P, Venter A, Thiel B, Debanne SA, Boom WH, Diacon AH, Johnson JL, Peloquin CA. Erratum for Alsultan et al., "Population Pharmacokinetics of AZD-5847 in Adults with Pulmonary Tuberculosis". Antimicrob Agents Chemother. 2018 01; 62(1). PMID: 29269434; PMCID: PMC5740305.
    Citations:    Fields:    
  84. Cox V, Furin J. World Health Organization recommendations for multidrug-resistant tuberculosis: should different standards be applied? Int J Tuberc Lung Dis. 2017 12 01; 21(12):1211-1213. PMID: 29297439.
    Citations: 1     Fields:    Translation:Humans
  85. Miller-Fellows SC, Howard L, Kramer R, Hildebrand V, Furin J, Mutuku FM, Mukoko D, Ivy JA, King CH. Cross-sectional interview study of fertility, pregnancy, and urogenital schistosomiasis in coastal Kenya: Documented treatment in childhood is associated with reduced odds of subfertility among adult women. PLoS Negl Trop Dis. 2017 Nov; 11(11):e0006101. PMID: 29176778.
    Citations: 11     Fields:    Translation:HumansAnimals
  86. Furin J, Lessem E, Cox V. Recommending prolonged bedaquiline use for the treatment of highly resistant strains of tuberculosis. Eur Respir J. 2017 11; 50(5). PMID: 29122918.
    Citations: 2     Fields:    Translation:Humans
  87. Reuter A, Tisile P, von Delft D, Cox H, Cox V, Ditiu L, Garcia-Prats A, Koenig S, Lessem E, Nathavitharana R, Seddon JA, Stillo J, von Delft A, Furin J. The devil we know: is the use of injectable agents for the treatment of MDR-TB justified? Int J Tuberc Lung Dis. 2017 11 01; 21(11):1114-1126. PMID: 29037291.
    Citations: 32     Fields:    Translation:Humans
  88. Furin J, Cox H. To Test or Not to Test? Ending the Age-Old Debate for Drug-Resistant Tuberculosis. Clin Infect Dis. 2017 10 01; 65(7):1212-1213. PMID: 28549086; PMCID: PMC5850638.
    Citations:    Fields:    Translation:Humans
  89. Mohr E, Daniels J, Muller O, Furin J, Chabalala B, Steele SJ, Cox V, Dolby T, Ferlazzo G, Shroufi A, Duran LT, Cox H. Missed opportunities for earlier diagnosis of rifampicin-resistant tuberculosis despite access to Xpert® MTB/RIF. Int J Tuberc Lung Dis. 2017 10 01; 21(10):1100-1105. PMID: 28911352; PMCID: PMC6548553.
    Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
  90. Alsultan A, Furin JJ, Du Bois J, van Brakel E, Chheng P, Venter A, Thiel B, Debanne SA, Boom WH, Diacon AH, Johnson JL, Peloquin CA. Population Pharmacokinetics of AZD-5847 in Adults with Pulmonary Tuberculosis. Antimicrob Agents Chemother. 2017 10; 61(10). PMID: 28739794; PMCID: PMC5610519.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  91. Vambe D, Dlamini T, Furin J, Gracia-Edwards C, Keus K, Kunene K, Shabangu A, Dlamini SN, Sikhondze W. Operational aspects of bedaquiline implementation in Swaziland: report from the field. Public Health Action. 2017 Sep 21; 7(3):240-242. PMID: 29201660; PMCID: PMC5677001.
    Citations: 2     
  92. Lessem E, Cox V, Furin J. Bedaquiline or delamanid for rifampin-resistant tuberculosis? Lancet Respir Med. 2017 10; 5(10):772-774. PMID: 28887015.
    Citations:    Fields:    Translation:HumansCells
  93. Cox H, Reuter A, Furin J, Seddon J. Prevention of hearing loss in patients with multidrug-resistant tuberculosis. Lancet. 2017 09 02; 390(10098):934. PMID: 28872029.
    Citations: 2     Fields:    Translation:Humans
  94. Harausz EP, Leigh J, Garcia-Prats AJ, Furin J, Peloquin CA. Stability of Second-Line Tuberculosis Medications Mixed With Milk or Yogurt. Clin Infect Dis. 2017 08 15; 65(4):704-705. PMID: 28482036.
    Citations: 1     Fields:    Translation:Animals
  95. Kunkel A, Furin J, Cohen T. Population implications of the use of bedaquiline in people with extensively drug-resistant tuberculosis: are fears of resistance justified? Lancet Infect Dis. 2017 12; 17(12):e429-e433. PMID: 28533094.
    Citations: 3     Fields:    Translation:Humans
  96. Harausz EP, Garcia-Prats AJ, Seddon JA, Schaaf HS, Hesseling AC, Achar J, Bernheimer J, Cruz AT, D'Ambrosio L, Detjen A, Graham SM, Hughes J, Jonckheere S, Marais BJ, Migliori GB, McKenna L, Skrahina A, Tadolini M, Wilson P, Furin J. New and Repurposed Drugs for Pediatric Multidrug-Resistant Tuberculosis. Practice-based Recommendations. Am J Respir Crit Care Med. 2017 05 15; 195(10):1300-1310. PMID: 27854508.
    Citations: 15     Fields:    Translation:Humans
  97. Pai M, Furin J. Tuberculosis innovations mean little if they cannot save lives. Elife. 2017 05 02; 6. PMID: 28460659; PMCID: PMC5413344.
    Citations: 19     Fields:    Translation:Humans
  98. Jonckheree S, Furin J. Overcoming challenges in the diagnosis, prevention, and treatment of pediatric drug-resistant tuberculosis. Expert Rev Respir Med. 2017 05; 11(5):385-394. PMID: 28319425.
    Citations: 1     Fields:    Translation:Humans
  99. Dheda K, Gumbo T, Maartens G, Dooley KE, McNerney R, Murray M, Furin J, Nardell EA, London L, Lessem E, Theron G, van Helden P, Niemann S, Merker M, Dowdy D, Van Rie A, Siu GK, Pasipanodya JG, Rodrigues C, Clark TG, Sirgel FA, Esmail A, Lin HH, Atre SR, Schaaf HS, Chang KC, Lange C, Nahid P, Udwadia ZF, Horsburgh CR, Churchyard GJ, Menzies D, Hesseling AC, Nuermberger E, McIlleron H, Fennelly KP, Goemaere E, Jaramillo E, Low M, Jara CM, Padayatchi N, Warren RM. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. Lancet Respir Med. 2017 Mar 15. PMID: 28344011.
    Citations: 168     Fields:    
  100. Weld ED, Garcia-Prats AJ, Furin JJ, Bailey TC, Hesseling AC, Dooley KE. The time has come: sparing injectables in paediatric MDR-TB. Lancet Respir Med. 2017 Mar 15. PMID: 28344008; PMCID: PMC9181438.
    Citations:    Fields:    
  101. Guglielmetti L, Hewison C, Avaliani Z, Hughes J, Kiria N, Lomtadze N, Ndjeka N, Setkina S, Shabangu A, Sikhondze W, Skrahina A, Veziris N, Furin J. Examples of bedaquiline introduction for the management of multidrug-resistant tuberculosis in five countries. Int J Tuberc Lung Dis. 2017 02 01; 21(2):167-174. PMID: 28234080; PMCID: PMC5664221.
    Citations: 10     Fields:    Translation:Humans
  102. Furin J, Diacon AH, Andries K. Combating drug-resistant tuberculosis: the unexpected benefits of bedaquiline. Int J Tuberc Lung Dis. 2017 01 01; 21(1):4-5. PMID: 28157457.
    Citations: 3     Fields:    Translation:Humans
  103. Furin J, Isaakidis P. Life in the time of antiretrovirals in South Africa. Lancet HIV. 2017 03; 4(3):e95-e96. PMID: 27956186.
    Citations:    Fields:    Translation:Humans
  104. Tierney DB, Milstein MB, Manjourides J, Furin JJ, Mitnick CD. Treatment Outcomes for Adolescents With Multidrug-Resistant Tuberculosis in Lima, Peru. Glob Pediatr Health. 2016; 3:2333794X16674382. PMID: 27826599; PMCID: PMC5084611.
    Citations: 5     
  105. Furin JJ, Du Bois J, van Brakel E, Chheng P, Venter A, Peloquin CA, Alsultan A, Thiel BA, Debanne SM, Boom WH, Diacon AH, Johnson JL. Early Bactericidal Activity of AZD5847 in Patients with Pulmonary Tuberculosis. Antimicrob Agents Chemother. 2016 11; 60(11):6591-6599. PMID: 27550361; PMCID: PMC5075064.
    Citations: 10     Fields:    Translation:HumansCells
  106. Dheda K, Chang KC, Guglielmetti L, Furin J, Schaaf HS, Chesov D, Esmail A, Lange C. Clinical management of adults and children with multidrug-resistant and extensively drug-resistant tuberculosis. Clin Microbiol Infect. 2017 Mar; 23(3):131-140. PMID: 27756712.
    Citations: 10     Fields:    Translation:HumansPHPublic Health
  107. Cariem R, Cox V, de Azevedo V, Hughes J, Mohr E, Durán LT, Ndjeka N, Furin J. The experience of bedaquiline implementation at a decentralised clinic in South Africa. Public Health Action. 2016 Sep; 6(3):190-192. PMID: 27695682; PMCID: PMC5034785.
    Citations: 5     
  108. Mafukidze A, Harausz E, Furin J. An update on repurposed medications for the treatment of drug-resistant tuberculosis. Expert Rev Clin Pharmacol. 2016 Oct; 9(10):1331-1340. PMID: 27376490.
    Citations: 5     Fields:    
  109. Koenig SP, Furin J. Update in Tuberculosis/Pulmonary Infections 2015. Am J Respir Crit Care Med. 2016 07 15; 194(2):142-6. PMID: 27420359; PMCID: PMC5003219.
    Citations: 4     Fields:    Translation:Humans
  110. Master I, Furin J. Access to new drugs and the global drug-resistant TB crisis: a case series from KwaZulu-Natal, South Africa. Int J Tuberc Lung Dis. 2016 07; 20(7):985-7. PMID: 27287655.
    Citations:    Fields:    Translation:Humans
  111. Tadolini M, Garcia-Prats AJ, D'Ambrosio L, Hewison C, Centis R, Schaaf HS, Marais BJ, Ferreira H, Caminero JA, Jonckheere S, Sinha A, Herboczek K, Khaidarkhanova Z, Hayrapetyan A, Khachatryan N, Urtkmelidze Ia, Loreti C, Esposito S, Matteelli A, Furin J, Varaine F, Migliori GB. Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges. Eur Respir J. 2016 09; 48(3):938-43. PMID: 27338197; PMCID: PMC5007219.
    Citations: 20     Fields:    Translation:Humans
  112. Kurz SG, Furin JJ, Bark CM. Drug-Resistant Tuberculosis: Challenges and Progress. Infect Dis Clin North Am. 2016 06; 30(2):509-522. PMID: 27208770; PMCID: PMC4876017.
    Citations: 32     Fields:    Translation:HumansCells
  113. Furin J, Cox H. Outbreak of multidrug-resistant tuberculosis on Daru Island. Lancet Respir Med. 2016 05; 4(5):347-9. PMID: 27016866.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  114. Furin J, Alirol E, Allen E, Fielding K, Merle C, Abubakar I, Andersen J, Davies G, Dheda K, Diacon A, Dooley KE, Dravnice G, Eisenach K, Everitt D, Ferstenberg D, Goolam-Mahomed A, Grobusch MP, Gupta R, Harausz E, Harrington M, Horsburgh CR, Lienhardt C, McNeeley D, Mitnick CD, Nachman S, Nahid P, Nunn AJ, Phillips P, Rodriguez C, Shah S, Wells C, Thomas-Nyang'wa B, du Cros P. Drug-resistant tuberculosis clinical trials: proposed core research definitions in adults. Int J Tuberc Lung Dis. 2016 Mar; 20(3):290-4. PMID: 27046707.
    Citations: 4     Fields:    Translation:HumansCells
  115. Furin J, Brigden G, Lessem E, Rich M, Vaughan L, Lynch S. Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis. Emerg Infect Dis. 2016 Mar; 22(3). PMID: 26885674; PMCID: PMC4766879.
    Citations: 10     Fields:    Translation:Humans
  116. Furin J, Isaakidis P. The tuberculosis emergency in eastern Europe. Lancet HIV. 2016 Mar; 3(3):e107-8. PMID: 26939731.
    Citations:    Fields:    Translation:Humans
  117. Benbaba S, Isaakidis P, Das M, Jadhav S, Reid T, Furin J. Direct Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO? PLoS One. 2015; 10(12):e0144936. PMID: 26713873.
    Citations: 13     Fields:    Translation:Humans
  118. Mafukidze AT, Calnan M, Furin J. Peripheral neuropathy in persons with tuberculosis. J Clin Tuberc Other Mycobact Dis. 2016 Jan; 2:5-11. PMID: 31768422; PMCID: PMC6852705.
    Citations: 7     
  119. Furin J, Mafukidze A, Brigden G, du Cros P, Golin R, Harausz E, Seddon JA, Ustero P, Garcia-Prats AJ. A bitter pill to swallow: the need for better medications for drug-resistant tuberculosis in children. Int J Tuberc Lung Dis. 2015 Dec 01; 19(12):55-60. PMID: 28871918.
    Citations:    
  120. Taneja R, Garcia-Prats AJ, Furin J, Maheshwari HK. Paediatric formulations of second-line anti-tuberculosis medications: challenges and considerations. Int J Tuberc Lung Dis. 2015 Dec 01; 19(12):61-68. PMID: 28871919.
    Citations:    
  121. Taneja R, Garcia-Prats AJ, Furin J, Maheshwari HK. Paediatric formulations of second-line anti-tuberculosis medications: challenges and considerations. Int J Tuberc Lung Dis. 2015 Dec; 19 Suppl 1:61-68. PMID: 26564545.
    Citations: 7     Fields:    Translation:Humans
  122. Furin J, Mafukidze A, Brigden G, du Cros P, Golin R, Harausz E, Seddon JA, Ustero P, Garcia-Prats AJ. A bitter pill to swallow: the need for better medications for drug-resistant tuberculosis in children. Int J Tuberc Lung Dis. 2015 Dec; 19 Suppl 1:55-60. PMID: 26564544.
    Citations: 5     Fields:    Translation:HumansCells
  123. Furin J, Akugizibwe P, Ditiu L, Gray G, Palmero D, Zaidi S. No one with HIV should die from tuberculosis. Lancet. 2015 Dec 05; 386(10010):e48-50. PMID: 26515682.
    Citations: 3     Fields:    Translation:Humans
  124. Furin J, Harausz E, Zimetbaum P, Cox H. In reply. QTc prolongation and delamanid: access and safety. Int J Tuberc Lung Dis. 2015 Oct; 19(10):1262-3. PMID: 26459548.
    Citations:    Fields:    Translation:Humans
  125. Reed C, Mason L, Cox H, Seaworth B, Lessem E, Furin J. Compassionate and optimum use of new tuberculosis drugs. Lancet Infect Dis. 2015 Oct; 15(10):1131. PMID: 26461942.
    Citations: 3     Fields:    Translation:Humans
  126. Monedero I, Furin J. Programmatic management of children with drug-resistant tuberculosis: common sense and social justice. Public Health Action. 2015 Jun 21; 5(2):92. PMID: 26393107; PMCID: PMC4487481.
    Citations:    
  127. Cox HS, Furin JJ, Mitnick CD, Daniels C, Cox V, Goemaere E. The need to accelerate access to new drugs for multidrug-resistant tuberculosis. Bull World Health Organ. 2015 Jul 01; 93(7):491-7. PMID: 26170507; PMCID: PMC4490806.
    Citations: 3     Fields:    Translation:Humans
  128. Furin J. Informed use of bedaquiline for tuberculosis. Lancet. 2015 May 02; 385(9979):1724-1725. PMID: 25943932.
    Citations:    Fields:    Translation:Humans
  129. Harausz E, Cox H, Rich M, Mitnick CD, Zimetbaum P, Furin J. QTc prolongation and treatment of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2015 Apr; 19(4):385-91. PMID: 25859992.
    Citations: 12     Fields:    Translation:Humans
  130. Brigden G, Furin J, Van Gulik C, Marais B. Getting it right for children: improving tuberculosis treatment access and new treatment options. Expert Rev Anti Infect Ther. 2015 Apr; 13(4):451-61. PMID: 25739933.
    Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
  131. Lessem E, Cox H, Daniels C, Furin J, McKenna L, Mitnick CD, Mosidi T, Reed C, Seaworth B, Stillo J, Tisile P, von Delft D. Access to new medications for the treatment of drug-resistant tuberculosis: patient, provider and community perspectives. Int J Infect Dis. 2015 Mar; 32:56-60. PMID: 25809757.
    Citations: 14     Fields:    Translation:Humans
  132. Furin J, Isaakidis P, Reid AJ, Kielmann K. 'I'm fed up': experiences of prior anti-tuberculosis treatment in patients with drug-resistant tuberculosis and HIV. Int J Tuberc Lung Dis. 2014 Dec; 18(12):1479-84. PMID: 25517815.
    Citations: 10     Fields:    Translation:Humans
  133. McKenna L, Frick M, Seaworth B, Furin J. The 'invisibility' of children with tuberculosis. J Public Health Policy. 2015 Feb; 36(1):123-5. PMID: 25409704.
    Citations: 2     Fields:    Translation:Humans
  134. Isaakidis P, Smith S, Majumdar S, Furin J, Reid T. Calling tuberculosis a social disease--an excuse for complacency? Lancet. 2014 Sep 20; 384(9948):1095. PMID: 25241715.
    Citations: 2     Fields:    Translation:Humans
  135. Tierney DB, Franke MF, Becerra MC, Alcántara Virú FA, Bonilla CA, Sánchez E, Guerra D, Muñoz M, Llaro K, Palacios E, Mestanza L, Hurtado RM, Furin JJ, Shin S, Mitnick CD. Time to culture conversion and regimen composition in multidrug-resistant tuberculosis treatment. PLoS One. 2014; 9(9):e108035. PMID: 25238411.
    Citations: 12     Fields:    Translation:Humans
  136. Patel N, Furin JJ, Willenberg DJ, Apollon Chirouze NJ, Vernon LT. HIV-related stigma in the dental setting: a qualitative study. Spec Care Dentist. 2015 Jan-Feb; 35(1):22-8. PMID: 25039662; PMCID: PMC4785592.
    Citations: 9     Fields:    Translation:Humans
  137. Jenkins HE, Gegia M, Furin J, Kalandadze I, Nanava U, Chakhaia T, Cohen T. Geographical heterogeneity of multidrug-resistant tuberculosis in Georgia, January 2009 to June 2011. Euro Surveill. 2014 Mar 20; 19(11). PMID: 24679722.
    Citations: 8     Fields:    Translation:HumansPHPublic Health
  138. Isaakidis P, Paryani R, Khan S, Mansoor H, Manglani M, Valiyakath A, Saranchuk P, Furin J. Poor outcomes in a cohort of HIV-infected adolescents undergoing treatment for multidrug-resistant tuberculosis in Mumbai, India. PLoS One. 2013; 8(7):e68869. PMID: 23894358.
    Citations: 31     Fields:    Translation:Humans
  139. Furin J, Brigden G, Lessem E, Becerra MC. Novel pediatric delivery systems for second-line anti-tuberculosis medications: a case study. Int J Tuberc Lung Dis. 2013 Sep; 17(9):1239-41. PMID: 23827936.
    Citations: 3     Fields:    Translation:Humans
  140. Gegia M, Jenkins HE, Kalandadze I, Furin J. Outcomes of children treated for tuberculosis with second-line medications in Georgia, 2009-2011. Int J Tuberc Lung Dis. 2013 May; 17(5):624-9. PMID: 23575328.
    Citations: 13     Fields:    Translation:HumansCells
  141. Seddon JA, Perez-Velez CM, Schaaf HS, Furin JJ, Marais BJ, Tebruegge M, Detjen A, Hesseling AC, Shah S, Adams LV, Starke JR, Swaminathan S, Becerra MC. Consensus Statement on Research Definitions for Drug-Resistant Tuberculosis in Children. J Pediatric Infect Dis Soc. 2013 Jun; 2(2):100-9. PMID: 23717785.
    Citations: 14     Fields:    
  142. Furin J, Mathew T. Tuberculosis control in acute disaster settings: case studies from the 2010 Haiti earthquake. Disaster Med Public Health Prep. 2013 Apr; 7(2):129-30. PMID: 24618162.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  143. Mitnick CD, Franke MF, Rich ML, Alcantara Viru FA, Appleton SC, Atwood SS, Bayona JN, Bonilla CA, Chalco K, Fraser HS, Furin JJ, Guerra D, Hurtado RM, Joseph K, Llaro K, Mestanza L, Mukherjee JS, Muñoz M, Palacios E, Sanchez E, Seung KJ, Shin SS, Sloutsky A, Tolman AW, Becerra MC. Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality. PLoS One. 2013; 8(3):e58664. PMID: 23516529.
    Citations: 30     Fields:    Translation:Humans
  144. Franke MF, Appleton SC, Mitnick CD, Furin JJ, Bayona J, Chalco K, Shin S, Murray M, Becerra MC. Aggressive regimens for multidrug-resistant tuberculosis reduce recurrence. Clin Infect Dis. 2013 Mar; 56(6):770-6. PMID: 23223591.
    Citations: 26     Fields:    Translation:HumansCellsPHPublic Health
  145. Lesia N, Miller AC, Rigodon J, Joseph JK, Furin J. Addressing gender inequity in HIV care in rural Lesotho: the 'Male Initiative'. Int Health. 2013 Mar; 5(1):72-7. PMID: 24029849.
    Citations:    Fields:    Translation:Humans
  146. Furin J, Miller AC, Lesia N, Cancedda C, Haidar M, Joseph K, Ramanagoaela L, Rigodon J. Gender differences in enrolment in an HIV-treatment programme in rural Lesotho, 2006-2008: a brief report. Int J STD AIDS. 2012 Oct; 23(10):689-91. PMID: 23104741.
    Citations:    Fields:    Translation:Humans
  147. Seddon JA, Furin JJ, Gale M, Del Castillo Barrientos H, Hurtado RM, Amanullah F, Ford N, Starke JR, Schaaf HS. Caring for children with drug-resistant tuberculosis: practice-based recommendations. Am J Respir Crit Care Med. 2012 Nov 15; 186(10):953-64. PMID: 22983960.
    Citations: 19     Fields:    Translation:Humans
  148. Drobac PC, Shin SS, Huamani P, Atwood S, Furin J, Franke MF, Lastimoso C, del Castillo H. Risk factors for in-hospital mortality among children with tuberculosis: the 25-year experience in Peru. Pediatrics. 2012 Aug; 130(2):e373-9. PMID: 22826566; PMCID: PMC3408686.
    Citations: 23     Fields:    Translation:HumansPHPublic Health
  149. Gegia M, Cohen T, Kalandadze I, Vashakidze L, Furin J. Outcomes among tuberculosis patients with isoniazid resistance in Georgia, 2007-2009. Int J Tuberc Lung Dis. 2012 Jun; 16(6):812-6. PMID: 22507372.
    Citations: 22     Fields:    Translation:HumansCells
  150. Miller AC, Gelmanova IY, Keshavjee S, Atwood S, Yanova G, Mishustin S, Furin JJ, Shin SS. Alcohol use and the management of multidrug-resistant tuberculosis in Tomsk, Russian Federation. Int J Tuberc Lung Dis. 2012 Jul; 16(7):891-6. PMID: 22507895.
    Citations: 14     Fields:    Translation:Humans
  151. Keshavjee S, Gelmanova IY, Shin SS, Mishustin SP, Andreev YG, Atwood S, Furin JJ, Miller A. Hepatotoxicity during treatment for multidrug-resistant tuberculosis: occurrence, management and outcome. Int J Tuberc Lung Dis. 2012 May; 16(5):596-603. PMID: 22410436.
    Citations: 11     Fields:    Translation:Humans
  152. Joseph JK, Rigodon J, Cancedda C, Haidar M, Lesia N, Ramanagoela L, Furin J. Lay health workers and HIV care in rural Lesotho: a report from the field. AIDS Patient Care STDS. 2012 Mar; 26(3):141-7. PMID: 22304374.
    Citations: 13     Fields:    Translation:Humans
  153. Jonsson G, Furin J. Will molecular diagnosis of drug-resistant tuberculosis improve patient outcomes? Int J Tuberc Lung Dis. 2012 Jan; 16(1):4-5. PMID: 22236840.
    Citations: 2     Fields:    Translation:HumansCells
  154. Jonsson G, Furin J. Will molecular diagnosis of drug-resistant tuberculosis improve patient outcomes? [Perspectives]. Int J Tuberc Lung Dis. 2012 Jan 01; 16(1):4-5. PMID: 29070307.
    Citations:    
  155. Gegia M, Kalandadze I, Madzgharashvili M, Furin J. Developing a human rights-based program for tuberculosis control in Georgian prisons. Health Hum Rights. 2011 Dec 15; 13(2):E73-81. PMID: 22773034; PMCID: PMC3734935.
    Citations: 4     Fields:    Translation:Humans
  156. Jonsson G, Furin J, Jeenah F, Moosa MY, Sivepersad R, Kalafatis F, Schoeman J. Human rights, mental illness, and HIV: the Luthando Neropsychiatric HIV Clinic in Soweto, South Africa. Health Hum Rights. 2011 Dec 15; 13(2):E64-72. PMID: 22773033.
    Citations: 5     Fields:    Translation:Humans
  157. Furin J, Gegia M, Mitnick C, Rich M, Shin S, Becerra M, Drobac P, Farmer P, Hurtado R, Joseph JK, Keshavjee S, Kalandadze I. Eliminating the category II retreatment regimen from national tuberculosis programme guidelines: the Georgian experience. Bull World Health Organ. 2012 Jan 01; 90(1):63-6. PMID: 22271966.
    Citations: 13     Fields:    Translation:HumansPHPublic Health
  158. Furin J. The role of traditional healers in community-based HIV care in rural Lesotho. J Community Health. 2011 Oct; 36(5):849-56. PMID: 21374087.
    Citations: 14     Fields:    Translation:Humans
  159. Furin J, Haidar M, Lesia N, Ramangoela L, Rigodon J. The role of the nurse in implementation of an HIV treatment program in rural Lesotho. J Assoc Nurses AIDS Care. 2012 Mar-Apr; 23(2):163-9. PMID: 21764607.
    Citations: 1     Fields:    Translation:Humans
  160. Furin J, Bayona J, Becerra M, Farmer P, Golubkov A, Hurtado R, Joseph JK, Keshavjee S, Ponomarenko O, Rich M, Shin S. Programmatic management of multidrug-resistant tuberculosis: models from three countries. Int J Tuberc Lung Dis. 2011 Oct; 15(10):1294-300. PMID: 21669029.
    Citations: 9     Fields:    Translation:Humans
  161. Furin JJ. Blood exposure at the 2010 International Federation of Football Association World Cup: time for universal adaptation of universal precautions. Clin J Sport Med. 2011 May; 21(3):264-5. PMID: 21519297.
    Citations:    Fields:    Translation:HumansPHPublic Health
  162. Furin J. Improving technical assistance for drug-resistant tuberculosis. Int J Tuberc Lung Dis. 2011 Mar; 15(3):421-2. PMID: 21333116.
    Citations:    Fields:    Translation:Humans
  163. Ivers LC, Mukherjee JS, Leandre FR, Rigodon J, Cullen KA, Furin J. South-south collaboration in scale-up of HIV care: building human capacity for care. AIDS. 2010 Jan; 24 Suppl 1:S73-8. PMID: 20023443; PMCID: PMC3169208.
    Citations: 6     Fields:    Translation:Humans
  164. Mathew TA, Shields AL, Imasheva A, Shin SS, Mishustin SP, Peremitin GG, Strelis AK, Yanova GV, Greenfield SF, Furin JJ. Knowledge, attitudes, and practices of physicians in Tomsk Oblast tuberculosis services regarding alcohol use among tuberculosis patients in Tomsk, Russia. Cult Med Psychiatry. 2009 Dec; 33(4):523-37. PMID: 19768525.
    Citations: 4     Fields:    Translation:Humans
  165. Seung KJ, Omatayo DB, Keshavjee S, Furin JJ, Farmer PE, Satti H. Early outcomes of MDR-TB treatment in a high HIV-prevalence setting in Southern Africa. PLoS One. 2009 Sep 25; 4(9):e7186. PMID: 19779624.
    Citations: 58     Fields:    Translation:HumansCells
  166. Keshavjee S, Gelmanova IY, Farmer PE, Mishustin SP, Strelis AK, Andreev YG, Pasechnikov AD, Atwood S, Mukherjee JS, Rich ML, Furin JJ, Nardell EA, Kim JY, Shin SS. Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study. Lancet. 2008 Oct 18; 372(9647):1403-9. PMID: 18723218.
    Citations: 63     Fields:    Translation:Humans
  167. Mitnick CD, Shin SS, Seung KJ, Rich ML, Atwood SS, Furin JJ, Fitzmaurice GM, Alcantara Viru FA, Appleton SC, Bayona JN, Bonilla CA, Chalco K, Choi S, Franke MF, Fraser HS, Guerra D, Hurtado RM, Jazayeri D, Joseph K, Llaro K, Mestanza L, Mukherjee JS, Muñoz M, Palacios E, Sanchez E, Sloutsky A, Becerra MC. Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med. 2008 Aug 07; 359(6):563-74. PMID: 18687637; PMCID: PMC2673722.
    Citations: 113     Fields:    Translation:HumansCells
  168. Satti H, Seung K, Keshavjee S, Furin J. Extensively drug-resistant tuberculosis, Lesotho. Emerg Infect Dis. 2008 Jun; 14(6):992-3. PMID: 18551748.
    Citations: 7     Fields:    Translation:HumansCells
  169. Furin J, Shutts M, Keshavjee S. Aviation and the delivery of medical care in remote regions: the Lesotho HIV experience. Aviat Space Environ Med. 2008 Feb; 79(2):136-8. PMID: 18309912.
    Citations: 1     Fields:    Translation:Humans
  170. Shin SS, Pasechnikov AD, Gelmanova IY, Peremitin GG, Strelis AK, Mishustin S, Barnashov A, Karpeichik Y, Andreev YG, Golubchikova VT, Tonkel TP, Yanova GV, Yedilbayev A, Rich ML, Mukherjee JS, Furin JJ, Atwood S, Farmer PE, Keshavjee S. Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia. Int J Tuberc Lung Dis. 2007 Dec; 11(12):1314-20. PMID: 18034952.
    Citations: 47     Fields:    Translation:Humans
  171. Keshavjee S, Gelmanova IY, Pasechnikov AD, Mishustin SP, Andreev YG, Yedilbayev A, Furin JJ, Mukherjee JS, Rich ML, Nardell EA, Farmer PE, Kim JY, Shin SS. Treating multidrug-resistant tuberculosis in Tomsk, Russia: developing programs that address the linkage between poverty and disease. Ann N Y Acad Sci. 2008; 1136:1-11. PMID: 17954675.
    Citations: 17     Fields:    Translation:HumansCellsPHPublic Health
  172. Furin JJ, Behforouz HL, Shin SS, Mukherjee JS, Bayona J, Farmer PE, Kim JY, Keshavjee S. Expanding global HIV treatment: case studies from the field. Ann N Y Acad Sci. 2008; 1136:12-20. PMID: 17954668.
    Citations: 7     Fields:    Translation:Humans
  173. Furin JJ, Rigodon J, Cancedda C, Keshavjee S, Seung KJ, Letsie M, Kim JY, Joseph JK. Improved case detection of active tuberculosis associated with an antiretroviral treatment program in Lesotho. Int J Tuberc Lung Dis. 2007 Oct; 11(10):1154-6. PMID: 17945074.
    Citations: 3     Fields:    Translation:Humans
  174. Furin J. The clinical management of drug-resistant tuberculosis. Curr Opin Pulm Med. 2007 May; 13(3):212-7. PMID: 17414129.
    Citations: 9     Fields:    Translation:HumansCells
  175. Chalco K, Wu DY, Mestanza L, Muñoz M, Llaro K, Guerra D, Palacios E, Furin J, Shin S, Sapag R. Nurses as providers of emotional support to patients with MDR-TB. Int Nurs Rev. 2006 Dec; 53(4):253-60. PMID: 17083413.
    Citations: 20     Fields:    Translation:Humans
  176. Somocurcio JG, Sotomayor A, Shin S, Portilla S, Valcarcel M, Guerra D, Furin J. Surgery for patients with drug-resistant tuberculosis: report of 121 cases receiving community-based treatment in Lima, Peru. Thorax. 2007 May; 62(5):416-21. PMID: 16928717.
    Citations: 14     Fields:    Translation:Humans
  177. Drobac PC, Mukherjee JS, Joseph JK, Mitnick C, Furin JJ, del Castillo H, Shin SS, Becerra MC. Community-based therapy for children with multidrug-resistant tuberculosis. Pediatrics. 2006 Jun; 117(6):2022-9. PMID: 16740844.
    Citations: 28     Fields:    Translation:Humans
  178. Shin SS, Pasechnikov AD, Gelmanova IY, Peremitin GG, Strelis AK, Mishustin S, Barnashov A, Karpeichik Y, Andreev YG, Golubchikova VT, Tonkel TP, Yanova GV, Nikiforov M, Yedilbayev A, Mukherjee JS, Furin JJ, Barry DJ, Farmer PE, Rich ML, Keshavjee S. Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia. Int J Tuberc Lung Dis. 2006 Apr; 10(4):402-8. PMID: 16602404.
    Citations: 46     Fields:    Translation:Humans
  179. Shin SS, Furin JJ, Alcántara F, Bayona J, Sánchez E, Mitnick CD. Long-term follow-up for multidrug-resistant tuberculosis. Emerg Infect Dis. 2006 Apr; 12(4):687-8. PMID: 16704823; PMCID: PMC3294679.
    Citations: 9     Fields:    Translation:HumansCells
  180. Rich ML, Socci AR, Mitnick CD, Nardell EA, Becerra MC, Bonilla C, Bayona J, Seung KJ, Furin J, Farmer PE, Mukherjee JS. Representative drug susceptibility patterns for guiding design of retreatment regimens for MDR-TB. Int J Tuberc Lung Dis. 2006 Mar; 10(3):290-6. PMID: 16562709.
    Citations: 6     Fields:    Translation:Humans
  181. Furin J, Farmer P, Wolf M, Levy B, Judd A, Paternek M, Hurtado R, Katz J. A novel training model to address health problems in poor and underserved populations. J Health Care Poor Underserved. 2006 Feb; 17(1):17-24. PMID: 16520503.
    Citations: 23     Fields:    Translation:Humans
  182. Furin J, Paternek M, Katz JT. Global health equity as the focus of graduate medical education. Med Educ. 2005 Nov; 39(11):1161. PMID: 16262835.
    Citations: 2     Fields:    
  183. Furin JJ, Johnson JL. Recent advances in the diagnosis and management of tuberculosis. Curr Opin Pulm Med. 2005 May; 11(3):189-94. PMID: 15818178.
    Citations: 5     Fields:    Translation:Humans
  184. Drobac PC, del Castillo H, Sweetland A, Anca G, Joseph JK, Furin J, Shin S. Treatment of multidrug-resistant tuberculosis during pregnancy: long-term follow-up of 6 children with intrauterine exposure to second-line agents. Clin Infect Dis. 2005 Jun 01; 40(11):1689-92. PMID: 15889370.
    Citations: 18     Fields:    Translation:HumansCellsPHPublic Health
  185. Furin, J., Walton, D., Farmer, P. . The ever-changing face of AIDS: Implications for patient care. AIDS: Global Policy and Practice. K. Mayer and H. Pizer, eds. 2005; 286-306.
  186. Shin S, Furin J, Bayona J, Mate K, Kim JY, Farmer P. Community-based treatment of multidrug-resistant tuberculosis in Lima, Peru: 7 years of experience. Soc Sci Med. 2004 Oct; 59(7):1529-39. PMID: 15246180.
    Citations: 31     Fields:    Translation:Humans
  187. Seung KJ, Joseph K, Hurtado R, Rich M, Shin S, Furin J, Leandre F, Mukherjee J, Farmer P. Number of drugs to treat multidrug-resistant tuberculosis. Am J Respir Crit Care Med. 2004 Jun 15; 169(12):1336-7; author reply 1337. PMID: 15187016.
    Citations: 2     Fields:    Translation:Humans
  188. Farmer PE, Furin JJ, Katz JT. Global health equity. Lancet. 2004 May 29; 363(9423):1832. PMID: 15172796.
    Citations: 18     Fields:    Translation:Humans
  189. Shin S, Furin J, Alcántara F, Hyson A, Joseph K, Sánchez E, Rich M. Hypokalemia among patients receiving treatment for multidrug-resistant tuberculosis. Chest. 2004 Mar; 125(3):974-80. PMID: 15006956.
    Citations: 16     Fields:    Translation:Humans
  190. Mukherjee JS, Rich ML, Socci AR, Joseph JK, Virú FA, Shin SS, Furin JJ, Becerra MC, Barry DJ, Kim JY, Bayona J, Farmer P, Smith Fawzi MC, Seung KJ. Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet. 2004 Feb 07; 363(9407):474-81. PMID: 14962530.
    Citations: 93     Fields:    Translation:Humans
  191. Furin, J and Johnson, J. Managing Tuberculosis in the United States: An Update. Resident and Staff Physician. 2004; 50(3):12-21.
  192. Mukherjee JS, Joseph JK, Rich ML, Shin SS, Furin JJ, Seung KJ, Sloutsky A, Socci AR, Vanderwarker C, Vasquez L, Palacios E, Guerra D, Viru FA, Farmer P, Del Castillo HE. Clinical and programmatic considerations in the treatment of MDR-TB in children: a series of 16 patients from Lima, Peru. Int J Tuberc Lung Dis. 2003 Jul; 7(7):637-44. PMID: 12870684.
    Citations: 11     Fields:    Translation:Humans
  193. Shin S, Guerra D, Rich M, Seung KJ, Mukherjee J, Joseph K, Hurtado R, Alcantara F, Bayona J, Bonilla C, Farmer P, Furin J. Treatment of multidrug-resistant tuberculosis during pregnancy: a report of 7 cases. Clin Infect Dis. 2003 Apr 15; 36(8):996-1003. PMID: 12684912.
    Citations: 18     Fields:    Translation:HumansCells
  194. Palacios E, Guerra D, Llaro K, Chalco K, Sapag R, Furin J. The role of the nurse in the community-based treatment of multidrug-resistant tuberculosis (MDR-TB). Int J Tuberc Lung Dis. 2003 Apr; 7(4):343-6. PMID: 12729339.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  195. Shin SS, Hyson AM, Castañeda C, Sánchez E, Alcántara F, Mitnick CD, Fawzi MC, Bayona J, Farmer PE, Kim JY, Furin JJ. Peripheral neuropathy associated with treatment for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2003 Apr; 7(4):347-53. PMID: 12729340.
    Citations: 11     Fields:    Translation:Humans
  196. Mitnick C, Bayona J, Palacios E, Shin S, Furin J, Alcántara F, Sánchez E, Sarria M, Becerra M, Fawzi MC, Kapiga S, Neuberg D, Maguire JH, Kim JY, Farmer P. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med. 2003 Jan 09; 348(2):119-28. PMID: 12519922.
    Citations: 158     Fields:    Translation:Humans
  197. Furin JJ, Mitnick CD, Shin SS, Bayona J, Becerra MC, Singler JM, Alcantara F, Castañieda C, Sanchez E, Acha J, Farmer PE, Kim JY. Occurrence of serious adverse effects in patients receiving community-based therapy for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2001 Jul; 5(7):648-55. PMID: 11467371.
    Citations: 46     Fields:    Translation:Humans
  198. Becerra MC, Freeman J, Bayona J, Shin SS, Kim JY, Furin JJ, Werner B, Sloutsky A, Timperi R, Wilson ME, Pagano M, Farmer PE. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2000 Feb; 4(2):108-14. PMID: 10694087.
    Citations: 18     Fields:    Translation:HumansCells
  199. Furin JJ, Becerra MC, Shin SS, Kim JY, Bayona J, Farmer PE. Effect of administering short-course, standardized regimens in individuals infected with drug-resistant Mycobacterium tuberculosis strains. Eur J Clin Microbiol Infect Dis. 2000 Feb; 19(2):132-6. PMID: 10746502.
    Citations: 8     Fields:    Translation:HumansCells
  200. Farmer, PE, Shin, SS, Bayona, J, Kim, JY, Furin, JJ, Brenner, A. . Making DOTS-Plus Work. Multidrug-Resistant Tuberculosis, Bastian,I and Portales, F eds. 2000; 285-302.